We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Maravai LifeSciences Holdings Inc | NASDAQ:MRVI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.17 | 1.93% | 8.97 | 8.22 | 9.46 | 9.1347 | 8.85 | 8.96 | 1,808,587 | 01:00:00 |
CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Delaware | 001-39725 | 85-2786970 | ||||||||||||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
10770 Wateridge Circle Suite 200 San Diego, California | 92121 | |||||||||||||
(Address of principal executive offices) | (Zip Code) | |||||||||||||
(858) 546-0004 | ||||||||||||||
(Registrant’s telephone number, including area code) | ||||||||||||||
Not Applicable (Former name or former address, if changed since last report.) | ||||||||||||||
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Class A Common Stock, $0.01 par value | MRVI | The Nasdaq Stock Market LLC | ||||||||||||
(Nasdaq Global Select Market) |
Emerging growth company | ☐ |
Exhibit No. | Description of Exhibit | |||||||
99.1* | ||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
* | Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing. |
MARAVAI LIFESCIENCES HOLDINGS, INC. | ||||||||
Date: February 22, 2023 | By: | /s/ Kevin M. Herde | ||||||
Name: | Kevin M. Herde | |||||||
Title: | Chief Financial Officer |
1 Year Maravai LifeSciences Chart |
1 Month Maravai LifeSciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions